cytarabine and ha14-1
cytarabine has been researched along with ha14-1 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Cox, J; Johnson, L; Lickliter, JD; McHugh, G; Tan, J; Wickham, NW; Wood, F; Wood, NJ | 1 |
Other Studies
1 other study(ies) available for cytarabine and ha14-1
| Article | Year |
|---|---|
HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death.
Topics: Apoptosis; Benzopyrans; Blast Crisis; Bone Marrow Cells; Cell Death; Cell Survival; Cytarabine; Drug Synergism; Enzyme Inhibitors; Genes, bcl-2; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma; Nitriles; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 2003 |